Literature DB >> 29936353

Rational modification of a lead molecule: Improving the antifungal activity of indole - triazole - amino acid conjugates.

Sahil Mishra1, Manpreet Kaur1, Subhash Chander2, Sankaranarayanan Murugesan2, Lovedeep Nim3, D S Arora3, Palwinder Singh4.   

Abstract

The modification of a molecule that was identified as highly efficacious in the previous studies could considerably improve the biological activity of the resulting compounds. While targeting lanosterol 14-α demethylase, the molecular modelling studies convinced that the extension of the phenyl ring of compound 1 deep into the hydrophobic pocket of the enzyme may increase the enzyme - ligand interactions and hence improve the anti-fungal profile of the molecules. As a result, the newly designed compounds 2 were synthesized and screened for their anti-microbial properties and these compounds were found to exhibit considerably better activity than the previous molecule 1. Some of the compounds in this series exhibited MIC90 16 μg mL-1 and 32 μg mL-1 against Candida albicans and Aspergillus niger, respectively as against 312 μg mL-1 for compound 1.
Copyright © 2018 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Antifungal; Indole-azole-amino acid conjugates; Quantitative structure activity relationship

Mesh:

Substances:

Year:  2018        PMID: 29936353     DOI: 10.1016/j.ejmech.2018.06.039

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  2 in total

Review 1.  1,2,3-Triazole-containing hybrids as leads in medicinal chemistry: A recent overview.

Authors:  Khurshed Bozorov; Jiangyu Zhao; Haji A Aisa
Journal:  Bioorg Med Chem       Date:  2019-07-04       Impact factor: 3.641

2.  The influence of the polymerization approach on the catalytic performance of novel porous poly (ionic liquid)s for green synthesis of pharmaceutical spiro-4-thiazolidinones.

Authors:  Zahra Elyasi; Javad Safaei Ghomi; Gholam Reza Najafi; Mohammad Reza Zand Monfared
Journal:  RSC Adv       Date:  2020-12-15       Impact factor: 4.036

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.